IMHO, the arguments for investing in Pfizer currently look like this:
Pfizer is a value play. PER of 9-10, yield 5%, not much debt, diverse income streams.
Pfizer is a play on covid continuing to be a pain in the ass for years to come.
Pfizer is a play on their new drug pipeline, with 90 meds in the pipeline before the SeaGen acquisition. In particular, danuglipron (or however it's spelled), their GLP-3 ozempic challenger which is oral and 2x faster working. Consider LLY/NVO jumped 50-60% this year on GLP-3 med success.
Pfizer is a mean-reversion play. It has dumped harder (in % terms) from peak than almost any other profit-making stock in the SP500, and certainly the hardest among the top 100, on relatively little news (most of it good). These things come and go. It will revert back to mean pharma valuation at some point.
Pfizer is a low-beta play. If we return to a bear-market or major correction, it will be a safe haven for equity investors as it was in 2022.
Finally, Pfizer is an anti-bubble stock that will go back to normality. There is a kind of cult of hate towards this stock by people who want covid to be over. It's like the opposite of the cult mentality around meme stocks. I think this keeps people from investing in Pfizer, they want to believe there can never be money again in covid, or they want to not think about covid, or whatever.
I'm not going to address arguments against Pfizer in this post, I'll write it up tomorrow maybe. Feel welcome to contribute any for/against points of your own below in the meantime.
Leave a Reply